Document is current

Any future updates will be listed below

Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13075-014-0451-y

Published Online: 2014-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark